ADAR1 Capital Management »

Oak Woods Acquisition Corp Cl A shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Oak Woods Acquisition Corp Cl A (OAKU) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Oak Woods Acquisition Corp Cl A

Tip: Access up to 7 years of quarterly data

All positions including Oak Woods Acquisition Corp Cl A held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oak Woods Acquisition Corp Cl A by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $316k 30k 10.53

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Oak Woods Acquisition Corp Cl A

Vivaldi Asset Management
Westchester Capital Management
Cowen And Company
Berkley W R
Kim
Glazer Capital
Exos TFP Holdings
Polar Securities
Hudson Bay Capital Management
CNH Partners
CVI Holdings
Fir Tree
D. E. Shaw & Co
DLD Asset Management
Tenor Capital Management

View all funds holding Oak Woods Acquisition Corp Cl A